Serum Progranulin Levels in Type 2 Diabetic Patients with Metabolic Syndrome

1. MIRANDA PJ, DEFRONZO RA, CLIFF RM and GUYTON JR. Metabolic syndrome: definition, pathophysiology and mechanisms. Am Heart J. 2005; 149: 33-45.10.1016/j.ahj.2004.07.013Search in Google Scholar

2. CAMERON AJ, SHAW JE and ZIMMET PZ. The metabolic syndrome: prevalence in worldwide populations, Endocrinol Metab Clin N Am. 2004; 33: 351-75.Search in Google Scholar

3. MARJANI A, HEZARKHANI S, SHAHIMI N. Prevalence of metabolic syndrome among Fars ethnic Women in north east of Iran. World J Med Sci.2012; 7(1):17-22.Search in Google Scholar

4. SHAHIMI N, SHAHIMI I, MARJANI A. Prevalence of metabolic syndrome in Turkmen ethnic groups in Gorgan. J Clin Diagn Res. 2013; 7(9):1849-51.Search in Google Scholar

5. MARJANI A, SHAHIMI N, AGHATABAY O, GHIYAS YABARI R. Prevalence of metabolic syndrome among sistanee ethnic women. Adv Stud Biol. 2012; 8(4):363-72.Search in Google Scholar

6. MARJANI A, SHAHIMI N. Age related metabolic syndrome among Fars ethnic women in Gorgan, Iran. J Pharm Biomed Sci. 2013; 30(30):929-35.Search in Google Scholar

7. MARJANI A, MOGHASEMI S. The Metabolic Syndrome among Postmenopausal Women in Gorgan. Int J Endocrinol. 2012; 2012:953627.10.1155/2012/953627Search in Google Scholar

8. GHIYAS YABARI M, NASERI F, PAAD E, MAJIDI F, MARJANI A. Prevalence of metabolic syndrome in Baluch women in Chabahar. International Journal of Osteoporosis and Metabolic Disorders. 2015; 8 (2): 27-34.10.3923/ijom.2015.27.34Search in Google Scholar

9. MARJANI A, ALIAKBARI F, ZAMAN KAMKAR M. Body mass index dependent metabolic syndrome in severe mental illness patients. International Journal of Osteoporosis and Metabolic Disorders. 2015; 8 (1): 19-26.10.3923/ijom.2015.19.26Search in Google Scholar

10. SHAFAEI A, KHOSHNIAM, MARJANI A. Serum level of fibroblast growth factor 21 in type 2 diabetic patients with and without metabolic syndrome. Journal of Medical Sciences. 2015; 15 (2): 80-86.10.3923/jms.2015.80.86Search in Google Scholar

11. MARJANI A. A review on the role of triglyceride in metabolic syndrome. Asian Journal of Pharmaceutical and Clinical Research. 2015; 8 (3): 1-3.Search in Google Scholar

12. MARJANI A. A review on the role of hypertension in the metabolic syndrome. Journal of Biological Sciences. 2013;13 (8): 685-690.10.3923/jbs.2013.685.690Search in Google Scholar

13. 13.MARJANI A, MOUJERLOO M, HEZARKHANI S. Age related metabolic syndrome among hemodialysis patients in Gorgan, Iran. Open Biochemistry Journal. 2013: 7 (1): 15-18.10.2174/1874091X01307010015Search in Google Scholar

14. MARJANI A, MOGHASEMI S. Serum vitamin D and metabolic syndrome among postmenopausal women in Gorgan. Biomedical Research. 2012; 23 (2): 275-280.Search in Google Scholar

15. MARJANI A, SHIRAFKAN A. The metabolic syndrome in type 2 diabetic patients in Gorgan: According to NCEP ATPIII and IDF definitions. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2011; 5 (4): 207-210.10.1016/j.dsx.2012.02.009Search in Google Scholar

16. MARJANI A, MOUJERLOO M. The metabolic syndrome in type 2 diabetic subjects in Gorgan, Iran. Journal of the Pakistan Medical Association. 2011; 61 (5): 458-461.Search in Google Scholar

17. ZANOCCO-MARANI T, BATEMAN A, ROMANO G, VALENTINIS B, HE ZH, BASERGA R. Biological activities and signaling pathways of the granulin/epithelin precursor. Cancer Res. 1999; 59:5331-5340.Search in Google Scholar

18. SHOYAB M, McDONALD VL, BYLES C, TODARO GJ, PLOWMAN GD. Epithelins 1 and 2: isolation and characterization of two cysteine rich growth-modulating proteins. Proc Natl Acad Sci. 1990; 87:7912-7916.10.1073/pnas.87.20.7912Search in Google Scholar

19. PLOWMAN GD, GREEN JM, NEUBAUER MG, et al. The epithelin precursor encodes two proteins with opposing activities on epithelial cell growth. J Biol Chem. 1992; 267:13073-13078.10.1016/S0021-9258(18)42382-4Search in Google Scholar

20. ANAKWE OO, GERTON GL. Acrosome biogenesis begins during meiosis: evidence from the synthesis and distribution of an acrosomal glycoprotein, acrogranin, during guinea pig spermatogenesis. Biol Reprod. 1990; 42:317-328.10.1095/biolreprod42.2.317Search in Google Scholar

21. ZHOU J, GAO G, CRABB JW, SERRERO G. Purification of an autocrine growth factor homologous with mouse epithelin precursor from a highly tumorigenic cell line. J Biol Chem. 1993; 268: 10863-10869.10.1016/S0021-9258(18)82064-6Search in Google Scholar

22. DANIEL R, HE Z, CARMICHAEL KP, HALPER J, BATEMAN A. Cellular localization of gene expression for progranulin. J Histochem Cytochem. 2000; 48:999-1009.10.1177/00221554000480071310858277Search in Google Scholar

23. LIU CJ. Progranulin: a promising therapeutic target for rheumatoid arthritis. FEBS Lett. 2011; 585: 3675-3680.10.1016/j.febslet.2011.04.065316208021550343Search in Google Scholar

24. HE Z and BATEMAN A. Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. Journal of Molecular Medicine. 2003; 81(10): 600-612.10.1007/s00109-003-0474-312928786Search in Google Scholar

25. BAKER M, MACKENZIE IR, PICKERING-BROWN SM, GASS J, RADEMAKERS R, LINDHOLM C, et al. Mutations in progranulin cause-negative frontotemporal dementia linked to chromosome 17. Nature. 2006; 442: 916-919.10.1038/nature0501616862116Search in Google Scholar

26. CRUTS M, GIJSELINCK I, VAN DER ZEE J, ENGELBORGHS S, WILS H, PIRICI D, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006; 442: 920-924.10.1038/nature0501716862115Search in Google Scholar

27. DANIEL R, DANIEL E, HE Z, BATEMAN A. Progranulin (acrogranin/PC cell-derived growth factor/granulin-epithelin precursor) is expressed in the placenta, epidermis, microvasculature, and brain during murine development. Dev Dyn. 2003; 227:593-599.10.1002/dvdy.1034112889069Search in Google Scholar

28. MARTENS LH, ZHANG J, BARMADA SJ, ZHOU P, KAMIYA S, SUN B, et al. Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury. J. Clin. Invest. 2012; 122: 3955-3959.10.1172/JCI63113348444323041626Search in Google Scholar

29. AHAMED Z, SHENG H, XU Y-F, LIN W-L, INNES AE, GASS J, et al. Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging. Am. J. Pathol.2010; 177: 311-324.Search in Google Scholar

30. YIN F, BANERJEE R, THOMAS B, ZHOU P, QIAN L, JIA T, et al. Exaggerated inflammation, impaired host defense, and neuropathology in progranulin deficient mice. J. Exp. Med.2010; 207: 117-228.Search in Google Scholar

31. TANG W, LU Y, TIAN Q-Y, ZHANG Y, GUO F-J, LIU G-Y, et al. The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science. 2011; 332: 478-484.10.1126/science.1199214310439721393509Search in Google Scholar

32. COPPOLA G, KARYDAS A, RARMAKERS R, WANG Q, BAKER M, HUTTON M, et al. Gene expression study on peripheral blood identifies progranulin mutations. Ann. Neurol. 2008; 64: 92-96.Search in Google Scholar

33. GHIDONI R, BENUSSI L, GLIONNA M and FRANZONI M. Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration. Neurology. 2008; 71: 1235-1239.10.1212/01.wnl.0000325058.10218.fcSearch in Google Scholar

34. FINCH N, BAKER M, CROOK R, SWANSON K, KUNTZ K, SURTEES R, et al. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Brain.2009; 132: 583-591.10.1093/brain/awn352Search in Google Scholar

35. YOUN B-S, BANG S-I, KLOETING N, PARK JW, LEE N, OH J-E, et al. Serum progranulin concentrations may be associated with macrophage infiltration into omental adipose tissue. Diabetes. 2009; 58: 627-636.10.2337/db08-1147Search in Google Scholar

36. CARECCHIO M, FENOGLIO C, De RIZ M, GUIDI I, COMI C, CORTINI F, et al. Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic mild cognitive impairment converted to Alzheimer’s disease. J. Neurol. Sci. 2009; 287: 291-293.Search in Google Scholar

37. HSIUNG GY, FOK A, FELDMAN HH, RADEMAKERS R and MACKENZIE IR rs5848 polymorphism and serum progranulin level. J. Neurol. Sci. 2011; 300: 28-32.Search in Google Scholar

38. ZHU J, NATHAN C, JIN W, SIM D, ASHCRFT GS, WAHL SM, et al. Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell. 2002; 111: 867-878.10.1016/S0092-8674(02)01141-8Search in Google Scholar

39. MATSUBARA T, MITA A, MINANI K, HOSOOKA T, KITAZAWA S, TAKAHASHI K, et al. PGRN is a key adipokine mediating high fat diet-induced insulin resistance and obesity through IL-6 in adipose tissue. Cell Metabolism. 2012; 15: 38-50.10.1016/j.cmet.2011.12.00222225875Search in Google Scholar

40. [No author listed], 2001, Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), JAMA. 2001; 285: 2486-97.10.1001/jama.285.19.248611368702Search in Google Scholar

41. World Health Organization. Prevention and Management of the Global Epidemic of Obesity. Report of the WHO Consultation on Obesity. WHO: Geneva (Technical Report Series, No. 894), 1998.Search in Google Scholar

42. RYDEN M. Fibroblast growth factor 21: an overview from a clinical perspective. Cell Mol Life Sci. 2009; 66: 2067-73.10.1007/s00018-009-0003-919277467Search in Google Scholar

43. OKURA H, YAMASHITA S, OHAMA T, SAGA A, YAMAMOTO-KAKUTA A, HAMADA Y. et al. HDL/apolipoprotein A-I binds to macrophage-derived progranulin and suppresses its conversion into proinflammatory granulins. J. Atheroscler. Thromb. 2010; 17: 568-577.Search in Google Scholar

44. NGUYEN AD, NGUYEN TA, CENIK B, YU G, HERZ J, TOBIAS C, et al. Secreted progranulin is a homodimer and is not a component of high density lipoproteins (HDL). The Journal of Biological Chemistry. 2013; 288(12): 8627-8635, 2013.Search in Google Scholar

45. YOO HJ, HWANG SY, HONG HC, CHOI HY, YANG SJ, CHOI DS, et al. Implication of progranulin and C1q/TNF-related protein-3 (CTRP3) on inflammation and atherosclerosis in subjects with or without metabolic syndrome. PLOS ONE. 2013; 8(2): e55744.10.1371/journal.pone.0055744356708623409033Search in Google Scholar

46. FAERCH K, VAAG A, WITTE DR, JORGENSEN T, PEDERSEN O, et al. Predictors of future fasting and 2-h post-OGTT plasma glucose levels in middle-aged men and women-the Inter 99 study. Diabet Med. 2009; 26(4): 377-383.10.1111/j.1464-5491.2009.02688.x19388967Search in Google Scholar

47. QU H, DENG H and HU Z. Plasma Progranulin Concentrations Are Increased in Patients with Type 2 Diabetes and Obesity and Correlated with Insulin Resistance. Mediators of Inflammation Volume, 2013, Article ID 360190, 6 pages.10.1155/2013/360190358818323476101Search in Google Scholar

48. ISMAIL NA, RAGAB S, ABD EL BAKY ANE, HAMED M, AYOUB DF. Relation between serum progranulin, inflammatory markers and visceral fat in childhood obesity. Advances in Bioscience and Biotechnology 2013; 4: 1030-1038.10.4236/abb.2013.412138Search in Google Scholar

49. American Diabetes Association Classification and diagnosis of diabetes. Diabetes Care. 2015; 38:S8-S16.10.2337/dc15-S00525537714Search in Google Scholar

50. TANAKA S, TANAKA S, IIMURO S, YAMASHITA H, KATAYAMA S, AKANUMA Y, et al. Predicting macro- and microvascular complications in type 2 diabetes. Diabetes Care. 2013; 36:1193-1199.10.2337/dc12-0958363182323404305Search in Google Scholar

51. XU L, ZHOU B, LI H, LIU J, DU J, ZANG W, et al. Serum levels of progranulin are closely associated with microvascular complication in type 2 diabetes. Dis Markers. 2015; 2015: 357279.10.1155/2015/357279446467826106251Search in Google Scholar

52. ZHOU M, TANG W, FU Y, XU X, WANG Z, LU Y, et al. Progranulin protects against renal ischemia/reperfusion injury in mice. Kidney Int. 2015; 87:918-929.10.1038/ki.2014.40325607110Search in Google Scholar